Tosoh Bioscience offers the G11 beta-thalassemia solution for laboratory diagnosis of haemoglobinopathies like beta-thalassemia. The solution allows for quantitative determination of HbF and HbA2 in 5 minutes with high resolution chromatographic separation of HbA2 and HbE. It provides a reliable, easy to use system with full reagent traceability and the ability to connect to automation lines. Haemoglobinopathies are among the most common inherited diseases worldwide due to global migration, and diagnosing variants like beta-thalassemia requires a number of laboratory tests on properties such as MCV, MCH, HbF, and HbA2 levels.
An educational leaflet by the Thalassaemia International Federation (TIF) with important information for β-thalassaemia patients on hematopoietic stem cell transplantation (HSCT), more commonly known as bone marrow transplantation (BMT).
Multiple Hepatic and Osseous Focal Lesions without Splenomegaly and/or Lymph ...JohnJulie1
Hepatic involvement is a common extranodal manifestation of common and some rare hematologic malignancies. Although the imaging features of more common hepatic diseases such as hepatocellular carcinoma, metastases, and infection may overlap with those of hepatic hematologic malignancies, combining the imaging features with clinical manifestations and laboratory findings can facilitate correct diagnosis. Imaging has an important role in diagnosis of hepatic focal lesions.
Hemophagocytic Lymphohistiocytosis (HLH) is an aggressive and life threatening syndrome which results from excessive immune activation, that can rapidly deteriorate and lead to multiple organ failure and death.
This booklet on the prevention and diagnosis of the haemoglobinopathies is intended to be a reference
booklet serving as a short guide directed towards health professionals and laboratory scientists undertaking haematological screening and molecular diagnosis of the thalassaemias and other haemoglobin disorders.
An educational leaflet by the Thalassaemia International Federation (TIF) with important information for β-thalassaemia patients on hematopoietic stem cell transplantation (HSCT), more commonly known as bone marrow transplantation (BMT).
Multiple Hepatic and Osseous Focal Lesions without Splenomegaly and/or Lymph ...JohnJulie1
Hepatic involvement is a common extranodal manifestation of common and some rare hematologic malignancies. Although the imaging features of more common hepatic diseases such as hepatocellular carcinoma, metastases, and infection may overlap with those of hepatic hematologic malignancies, combining the imaging features with clinical manifestations and laboratory findings can facilitate correct diagnosis. Imaging has an important role in diagnosis of hepatic focal lesions.
Hemophagocytic Lymphohistiocytosis (HLH) is an aggressive and life threatening syndrome which results from excessive immune activation, that can rapidly deteriorate and lead to multiple organ failure and death.
This booklet on the prevention and diagnosis of the haemoglobinopathies is intended to be a reference
booklet serving as a short guide directed towards health professionals and laboratory scientists undertaking haematological screening and molecular diagnosis of the thalassaemias and other haemoglobin disorders.
Thalassemia Care and Research
Elliott Vichinsky, M.D.
January 18, 2014
Thalassemia Patient and Family Conference
Northern California Comprehensive Thalassemia Center
Children's Hospital Oakland
Global distribution and description of the thalassemia disorders, treatment and complications.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Thalassemia Care and Research
Elliott Vichinsky, M.D.
January 18, 2014
Thalassemia Patient and Family Conference
Northern California Comprehensive Thalassemia Center
Children's Hospital Oakland
Global distribution and description of the thalassemia disorders, treatment and complications.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Brochure-G11-B-Thal-EN.pdf
1. TOSOH BIOSCIENCE
G11
bThal
EN
Rev
10082017
-
10-2017
HLC-723G11
ß-THALASSAEMIA ANALYSIS MODE
THE ULTIMATE HAEMOGLOBINOPATHY
SOLUTION FOR YOUR LAB
CHROMATOGRAM INTERPRETATION AIDS
• Software to assist in the interpretation of chromatograms
• Tosoh Bioscience offers an on-line clinical interpretation platform under the supervision of
highly knowledgeable experts in the field
Example chromatograms: Normal, ß-Thalassaemia trait, HbS trait, HbE trait
References
1. Angastiniotis M, Vives Corrons J-L, Soteriades ES, Eleftheriou A. The Impact of Migrations on the Health Services
for Rare Diseases in Europe: The example of Haemoglobin Disorders, in: The Scientific World Journal Volume 2013
2. Haemoglobinopathies on the move: Is Europe ready? Report by group of experts from the European Network for
Rare and Congenital Anaemias (ENERCA) and the Thalassemia International Federation (TIF) in collaboration with
the International Organization for Migration (IOM), Migration Health Division, Regional Office Brussels
3. Weatherall DJ, Clegg JB. 2001. The thalassaemia syndromes. 4th Edition. Oxford: Blackwell Science Ltd 2001
4. Thein SL. The molecular basis of ß-thalassemia. Cold Spring Harb Perspect Med. 2013 May 1;3(5)
5. Cao A, Kan YW. The prevention of thalassemia. Cold Spring Harb Perspect Med. 2013 Feb 1;3(2)
Tosoh Europe N.V.
Transportstraat 4 - 3980 Tessenderlo - BELGIUM
Tel: +32 (0)13 66 88 30 - Fax: +32 (0)13 66 47 49
www.tosohbioscience.eu
Tosoh Bioscience Ltd
100 Longwater Avenue, Green Park,
Reading RG2 6GP - UNITED KINGDOM
Tel: +44 (0) 1527 592901 - Fax: +44 (0) 1527 592902
www.tosohbioscience.eu
Tosoh Europe International N.V. (DMCC Branch)
Unit N°: 1605, Jumeirah Bay Tower X3
Plot N°: JLT-PH2-X3A
Jumeirah Lakes Towers, Dubai - UNITED ARAB EMIRATES (UAE)
Tosoh Bioscience Division
Shiba-Koen First Bldg. 3-8-2, Shiba, Minato-ku,
Tokyo 105-8623 - JAPAN
Tel: +81 3 5427 5181 - Fax: +81 3 5427 5220
www.tosoh.com
“HLC” and “HLC-723” are the registered trademark of Tosoh Corporation in EU, etc.
2. LABORATORY DIAGNOSIS TOSOH G11 BETA-THALASSAEMIA SOLUTION
Haemoglobinopathies are among the most common hereditary
diseases of the world’s population. About 4.5% of all human beings
carry a gene for a thalassaemia or haemoglobin anomaly(1)
. The areas
in which such abnormalities were originally most common extend
from Africa over the Mediterranean basin and the Near- and Middle
East to Southeast Asia and the Indian subcontinent. Global migration
in the modern period has led to a continual spread of these anomalies
to all regions of the world, with the result that they are rapidly
becoming more common in the industrialised regions of Northern and
Central Europe as well(2)
.
Variants of thalassaemias and main abnormal haemoglobins interact to produce a wide range
of clinical disorders of varying severity(3-4)
. Homozygotes for ß-thalassaemia may develop either
thalassaemia major or thalassaemia intermedia. Individuals with thalassaemia major are usually
diagnosed within the first 2 years of life and require regular blood transfusions to survive(5)
.
Thalassaemia
HbS
HbC
HbE
HbD
Diagnosis of Beta-Thalassaemia and other types of haemoglobinopathies should be done based on clinical
symptoms (if available) and a number of laboratory tests, such as MCV, MCH, total red cell count, HbF, HbA2
and iron markers.
As a guideline, the below scheme can be used (Adapted from Mosca et at. J.Clin.Pathol. 2009 – with permission)
• Quantitative determination of HbF and HbA2 in 5 minutes
• Chromatographic separation between HbA2 and HbE
• High resolution chromatogram thanks to Tosoh’s over
40 years’ experience in HPLC
• Full reagent traceability
• Easy to use and intuitive instrument
• Highly reliable system
• Instrument connectable to open laboratory automation lines
normal
or
reduced
normal
normal
or
reduced
<1%
<1% or
increased
<1%
altered normal
altered
iron
deficiency
iron
deficiency
normal
or
increased
normal
increased
or reduced
normal
or
increased
<1%
<1% or
increased
<1%
normal normal
normal normal
α-thal traits
Norm. HbA2
β thal carriers
α-gene triplications
Hb variants with
β or α-
thalassaemia
phenotype
Some unstable
Hb variants
α-thal carrier
Large β thal
deletions
δ β thalassaemia
γ δ β thalassaemia
α-Gap-PCR
α or δ sequence
α-MLPA
β-Gap-PCR
γ-sequence
β-MLPA
β-sequence
β or α-sequence
α-Gap-PCR
α-MLPA
Gap-PCR
α or δ sequence
α and β-MLPA
β-Gap-PCR
γ-sequence
β-MLPA
normal
or
reduced
normal
normal
or
reduced
reduced reduced reduced reduced
MCV
MCH
RBC
HbF
IRON
MARKERS
POSSIBLE
DIAGNOSIS
MOLECULAR
CONFIRMATION
normal
or
increased
normal
normal
or
increased
<1% <1-8%
<1% 3 - 16% 3 - 16%
normal normal normal
normal
δ or α-gene
defects
HPFH
High HbA2
β thal carrier
normal
reduced
< 2.3%
HbA2
normal
2.3 - 3.5%
borderline
3.6 - 4.0%
increased
4.1 - 8.0%
MLPA: Multiplex ligation-dependent probe amplification